155 related articles for article (PubMed ID: 6800090)
1. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
[TBL] [Abstract][Full Text] [Related]
2. The morphologic effects of mitomycin C in mammalian urinary bladder.
Murphy WM; Soloway MS; Crabtree WN
Cancer; 1981 Jun; 47(11):2567-74. PubMed ID: 6790156
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
Hickey DP; Brausi M; Blatnik AF; Soloway MS
Urology; 1987 Nov; 30(5):484-7. PubMed ID: 3118551
[TBL] [Abstract][Full Text] [Related]
4. Intravesical single and combination therapy in superficial bladder cancer. An experimental study.
Rübben H; Dahm HH; von Uelft W; Rüttgers L; Friedrichs R; Lutzeyer W
Eur Urol; 1982; 8(5):284-90. PubMed ID: 7117342
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo.
Bahnson R; Ratliff TL
J Urol; 1988 Sep; 140(3):656-9. PubMed ID: 2457714
[TBL] [Abstract][Full Text] [Related]
6. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
7. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
[TBL] [Abstract][Full Text] [Related]
8. [Intravesical chemotherapy in superficial tumors of the bladder].
Schulman CC
Arch Esp Urol; 1983; 36(1):32-40. PubMed ID: 6409013
[No Abstract] [Full Text] [Related]
9. Chemoimmunotherapy of implanted murine bladder cancer.
Akaza H; Crabtree WN; Matheny RB; Soloway MS
Urology; 1983 Mar; 21(3):273-6. PubMed ID: 6404034
[TBL] [Abstract][Full Text] [Related]
10. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Soloway MS; Cox CE
Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
[TBL] [Abstract][Full Text] [Related]
11. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
Nieh PT; Daly JJ; Irwin RJ; Prout GR
Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
[TBL] [Abstract][Full Text] [Related]
12. [Intravesical chemotherapy for superficial bladder tumors].
Ohmori H
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
[TBL] [Abstract][Full Text] [Related]
13. Histopathological effects and recovery rate of rat bladders following intravesical instillation of thiotepa, doxorubicin and mitomycin C.
Chang SY; Yu DS; Wang J; Ma CP
Br J Urol; 1990 Dec; 66(6):623-7. PubMed ID: 2124941
[TBL] [Abstract][Full Text] [Related]
14. Intravesical chemotherapy in the United States. An overview.
Spaulding JT
Cancer Chemother Pharmacol; 1983; 11 Suppl():S5-8. PubMed ID: 6196136
[TBL] [Abstract][Full Text] [Related]
15. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
Soloway MS
Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
[TBL] [Abstract][Full Text] [Related]
16. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Groos E; Walker L; Masters JR
Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Hofmann W; Langkopf B
Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
[No Abstract] [Full Text] [Related]
18. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
19. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
Daskal Y; Soloway MS; DeFuria MD; Crooke ST
Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
[TBL] [Abstract][Full Text] [Related]
20. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
